SCHEMBL1473989

SCHEMBL1473989

O=C(NCCc1cccnc1)c1cc(-c2ccc([N+](=O)[O-])cc2)on1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.60
RAB9A P51151 5/20 0.60
KMT2A Q03164 3/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
NPC1 O15118 5/20 0.59
TP53 P04637 3/20 0.59
LMNA P02545 2/20 0.59
POLB P06746 1/20 0.59
KDM4E B2RXH2 2/20 0.56
MEN1 O00255 2/20 0.56
HSD17B10 Q99714 2/20 0.56
PKM P14618 2/20 0.52
HPGD P15428 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C19 P33261 1/20 0.52
MAPT P10636 3/20 0.50
ALDH1A1 P00352 3/20 0.50
HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1475551 0.90 ALDH1A1 (0.60) FAAHRAB9AKMT2ASMN1; SMN2NPC1
SCHEMBL1474976 0.88 FAAH (0.61) FAAHTP53LMNAPOLBHSD17B10
SCHEMBL1473795 0.86 FAAH (0.66) FAAHRAB9AKMT2ASMN1; SMN2NPC1
SCHEMBL1475308 0.86 RAB9A (0.79) FAAHRAB9AKMT2ASMN1; SMN2NPC1
SCHEMBL1474640 0.85 FAAH (0.65) FAAHRAB9AKMT2ASMN1; SMN2NPC1
SCHEMBL1475220 0.85 FAAH (0.65) FAAHRAB9AKMT2ASMN1; SMN2NPC1
SCHEMBL15190450 0.85 NAMPT (0.45) FAAHRAB9AKMT2ASMN1; SMN2NPC1
SCHEMBL1474720 0.83 FAAH (0.70) FAAHRAB9AKMT2ASMN1; SMN2NPC1
SCHEMBL1476381 0.81 RAB9A (0.63) FAAHRAB9AKMT2ASMN1; SMN2NPC1
SCHEMBL16373636 0.80 FAAH (0.77) FAAHRAB9AKMT2ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-20090131336-A1 Isoxazole Derivatives and Use Thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2009-05-21 US disclosed
WO-2007078113-A1 ISOXAZOLE DERIVATIVES AND USE THEREOF SK HOLDINGS CO., LTD. (KR) 2007-07-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131336-A1 Isoxazole Derivatives and Use Thereof WNT3A, WNT1, WNT3 FAAH 4712/4885RAB9A 2013/4885KMT2A 4661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.